Clinical Trials · NCT00679042
Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- CellTrans Inc.
- Enrollment
- 21
- Start date
- Sep 2007
- Locations
- 1 site, United States
- Primary endpoint
- Treatment Emergent Adverse Events